EFNB2 negative
|
Cholangiocarcinoma
|
EFNB2 negative
|
Cholangiocarcinoma
|
sEphB4-HSA Sensitive: C3 – Early Trials
|
sEphB4-HSA Sensitive: C3 – Early Trials
|
EFNB2 negative
|
HCC
|
EFNB2 negative
|
HCC
|
sEphB4-HSA Sensitive: C3 – Early Trials
|
sEphB4-HSA Sensitive: C3 – Early Trials
|